Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

Plain-language summary

This study looks at local hyperthermia delivered with an infrared heating device combined with a topical 3% hydrogen peroxide solution in people with treatment-resistant viral warts. People whose warts have lasted 2 years or more and who have not responded to at least two prior treatments (such as ointments, cryotherapy, or laser) may take part. It is a study without a phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Recruiting

Sponsor

First Hospital of China Medical University

Intervention

An infrared hyperthermia device, Hydrogen Peroxide 3 % Topical Solution, Normal Saline (NS)

Start date

10/1/2025

Estimated completion

12/30/2027

Countries

China

Related genes

Locations

• Shenyang, China
• Shenyang, China

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

\- 1: Patients with a disease course of ≥2 years who have failed to respond to ≥2 treatment methods (such as topical ointments, cryotherapy, laser therapy, etc.)

2: The subject or their legal guardian is able to understand and sign the informed consent form/agree to participate in the study.

Exclusion Criteria:

* 1: The subject or their legal guardian is unable to understand and refuses to sign the informed consent form / refuses to participate in the study

  2: Individuals allergic to local hyperthermia or hydrogen peroxide;

  3: Subjects with tumors or other serious diseases are unable to complete this clinical study;

  4: Due to personal or other objective reasons, it is not possible to ensure timely treatment and follow-up.